Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
Mail & Guardian (Johannesburg) - August 15, 2002
All permanent employees, spouses or their life partners would be allowed to join the programme and would have access to the drugs during a two-year pilot period. The company will review its position after the trial.
Disclosing costs: The scope for massive under-disclosure of HIV/Aids costs was outlined this week by Andrew Sykes, CEO of NMG-LEVY, employee benefits consultant and a provider of HIV/Aids programmes to the corporate sector.
Sykes was speaking during a presentation, HIV/Aids Reporting for South African Business, in Johannesburg at an event calling for effective reporting guidelines.
The South African Institute of Chartered Accountants and the stock exchange are expected to release guidelines for listed companies early next year. It will be the first time any country has insisted on HIV/Aids reporting by companies, leading some to fear it will be treated as a symbolic first step rather than an opportunity to create effective reporting structures.
Source: Sapa
020815
MG020803
Copyright © 2002 - Daily Mail & Guardian. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .